The purpose of this page is to define regimen classes that will be used in the HemOnc vocabulary; it is not for other purposes at this time.
Alkylator-based regimen
Anthracycline-based regimen
Anti-CD20-based regimen
Rituximab-containing regimen
Anti-HER2-based regimen
Trastuzumab-based regimen
Anti-VEGF biologic therapy
Bevacizumab-containing regimen
Endocrine-based regimen
Androgen receptor-directed therapy
Antiestrogen therapy
Fludarabine-based regimen
Fluoropyrimidine-based regimen
5-FU-based regimen
Irinotecan-based regimen
Pemetrexed-containing regimen
Platinum-based regimen
Oxaliplatin-based regimen
Platinum-based chemoradiation
Platinum doublet
Single-agent regimen
Single-agent cytotoxic chemotherapy
Single-agent hormonotherapy
Single-agent immunotherapy
Single-agent targeted therapy
Taxane-based regimen
Tyrosine kinase inhibitor therapy
BRAF TKI therapy
EGFR TKI therapy
VEGFR inhibitor therapy